Are Options Traders Bullish on ADRO?
Let daily Option Order Flow show you where stock investors are Bullish and Bearish!!! Receive a FREE daily email of the Market Chameleon Order Flow Sentiment Newsletter.
Market Chameleon
Aduro Biotech Inc.

ADRO

7.00

-0.05

-0.7%

Please Login or Register

Login|Register FREE

Please Login or Register

Login|Register FREE

Stock Price
Open: 7.05
Prev. Close: 7.05
Low/Hi: 6.90 - 7.05
52-Week: 5.82 - 14.05
Volumes
Equity: 47,985
90-Day Avg: 479,011
Option: 160
90-Day Avg: 102
Volatility
Todays Stock Vol: 23.7
20-Day (HV): 54.4
52-Week (HV): 61.7
30-Day IV: 60.0 +10.2
IV Pct Rank: 10% Subdued
Fundamental
Div. Yield:
Earnings: 2-Aug (Est.)
P/E Ratio:
Market Cap: 555.0 M
Short Int Pct: 0.0%
Pct Held By Inst.: 68.5%
Stock Info
Type: Common
Sector: Healthcare
Industry: Biotechnology

About ADRO

Aduro Biotech, Inc. is a clinical-stage immuno-oncology company focused on the development of technology platforms to stimulate an immune response against cancer. Aduros lead platform is based on proprietary strains of live-attenuated, double-deleted (LADD) Listeria monocytogenes that induce a potent innate immune response and have been engineered to express tumor-associated antigens to induce tumor-specific T cell-mediated immunity. Aduro has received Breakthrough Therapy designation from the FDA for its lead LADD regimen, CRS-207 in combination with GVAX Pancreas in pancreatic cancer. The company is evaluating the proprietary immuno-oncology combination in the ongoing Phase 2b ECLIPSE clinical trial and has additional ongoing clinical trials with its LADD platform in mesothelioma and glioblastoma. The company is also developing clinical candidates using cyclic dinucleotide (CDN) synthetic small molecule immune modulators that are designed to activate the intracellular STING receptor, a central mediator of the innate immune response.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

ADRO is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
BIB ProShares Ultra Nasdaq Biotechnology 367.9 M 3.6791E+08 203 203 0.02% 0.000243883 198 K 197760
EQWS Invesco Russell 2000 Equal Weight ETF 26.0 M 2.6E+07 1,986 1986 0.03% 0.00026 7 K 6807
FHLC Fidelity MSCI Health Care Index ETF 1.2 B 1.2E+09 354 354 0.01% 6.63264E-05 82 K 81947
IBB iShares Nasdaq Biotechnology Index Fund 9.6 B 9.59496E+09 192 192 0.07% 0.0007 6.2 M 6243060
ITOT iShares Core S&P Total U.S. Stock Market ETF 14.9 B 1.49391E+10 3,452 3452 0.0% 0 89 K 88570
IWM iShares Russell 2000 ETF 47.5 B 4.7459E+10 2,018 2018 0.02% 0.0002 9.0 M 9035870
IWO iShares Russell 2000 Growth ETF 11.2 B 1.12322E+10 1,220 1220 0.04% 0.0004 4.2 M 4221670
IWV iShares Russell 3000 ETF 9.6 B 9.62607E+09 3,003 3003 0.0% 0 72 K 72121
ONEQ Fidelity Nasdaq Composite Index Tracking Stock 1.9 B 1.9E+09 973 973 0.01% 8.60154E-05 167 K 167090
SBIO ALPS Medical Breakthroughs ETF 229.2 M 2.29153E+08 115 115 0.35% 0.0035 802 K 802035
UBIO Proshares UltraPro Nasdaq Biotechnology 33.1 M 3.30685E+07 197 197 0.01% 0.000109009 12 K 12415
URTY ProShares UltraPro Russell2000 182.0 M 1.82002E+08 2,028 2028 0.0% 3.75058E-05 23 K 22983
UWM ProShares Ultra Russell2000 260.1 M 2.60074E+08 2,028 2028 0.01% 6.7242E-05 39 K 39240

Wait, Before You Leave...